AML Electronic Decision Aid

Not Applicable

Completed

• Conditions: Acute Myeloid Leukemia
• Interventions: Other: Electronic Decision Aid Tool

• Registration Number: NCT03442452
• Lead Sponsor: Duke University

Brief Summary

The purpose of this study is to test the feasibility and preliminary efficacy of a novel electronic decision aid to improve AML patients' understanding of their illness, prognosis, and treatment options.

Detailed Description

The purpose of this study is to test the feasibility and preliminary efficacy of a novel electronic decision aid to improve AML patients' understanding of their illness, prognosis, and treatment options. The objective of our program of research is to ultimately improve understanding about what patients with Acute Myeloid Leukemia (AML) know and understand about their disease, as well as what kind of information AML patients want or need to further inform them about the treatment decisions they face.

The AML Decision Aid tool consists of ten video modules, approximately 3 minutes each, containing content regarding key areas such as an explanation of what AML is, treatment choices, and things to consider when determining a treatment path. Recruited subjects will complete a series of surveys, both before viewing of the videos and after

Study Timeline

• Study First Submitted: 2018-02-02
• Study Start: 2018-02-07
• Study First Submitted QC: 2018-02-20
• Study First Posted: 2018-02-22
• Primary Completion: 2019-02-01
• Study Completion: 2019-02-01
• Status Verified: 2019-03
• Last Update Submitted: 2019-10-11
• Last Update Posted: 2019-10-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• At least age 18

• Capacity to give consent

• Diagnosis of acute myeloid leukemia (AML)

• Fluent in English

• Receiving care at Duke, and fits into one of the following scenarios:

  • has not yet made a treatment decision (in the DCI clinics or on the inpatient wards),
  • have recently made a decision (in the last 6 weeks), and are admitted for chemotherapy on 9100 or in the oncology treatment center to receive outpatient therapy,
  • or, during remission, while receiving consolidation chemotherapy in the hospital

Read More

Exclusion Criteria

• Patients too sick to participate per clinician discretion

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Electronic Decision Aid	Electronic Decision Aid Tool	For this study, we will be testing a novel electronic decision aid to improve Acute Myeloid Leukemia patients' understanding of their illness, prognosis, and treatment options.

Primary Outcome Measures

Name	Time	Method
Number of enrolled subjects who have completed the study	1 day	Feasibility will be determined by enrolled subjects who complete the study (including watching all videos, and completing the surveys).

Secondary Outcome Measures

Name	Time	Method
Change in knowledge about AML after video viewing	Day 1. Pre-video screening and post-video	Efficacy will be measured by change in knowledge about AML, (including knowledge about the disease itself, and comprehending AML treatment choices and their risks, as measured through changes in AML Knowledge Questionnaire scores)

Trial Locations

Locations (1)

Duke University Medical Center; 🇺🇸 Durham, North Carolina, United States